Merck Kgaa ADR (MKKGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 23,874,800 | 22,892,910 | 22,720,720 | 23,423,630 | 23,291,690 |
| Cost of Goods | 9,906,538 | 9,382,889 | 9,307,780 | 8,984,047 | 8,696,968 |
| Gross Profit | 13,968,260 | 13,510,020 | 13,411,860 | 14,439,590 | 14,593,540 |
| Operating Expenses | 9,895,760 | 9,565,570 | 9,506,620 | 9,725,830 | 9,652,700 |
| Operating Income | 4,074,171 | 3,944,254 | 3,906,021 | 4,713,807 | 4,944,175 |
| Interest Expense | 457,086 | 334,369 | 348,501 | 291,847 | 375,043 |
| Other Income | 125,586 | 216,421 | 213,213 | 94,823 | 73,352 |
| Pre-tax Income | 3,742,671 | 3,826,306 | 3,770,733 | 4,516,783 | 4,642,484 |
| Income Tax | 784,060 | 812,657 | 703,495 | 998,813 | 1,016,283 |
| Net Income Continuous | 2,958,611 | 3,014,731 | 3,067,238 | 3,517,970 | 3,626,201 |
| Minority Interests | 7,920 | 9,739 | 10,823 | 14,750 | 11,831 |
| Net Income | $2,950,691 | $3,004,992 | $3,056,415 | $3,503,220 | $3,614,370 |
| EPS Basic Total Ops | 1.36 | 1.38 | 1.40 | 1.61 | 1.66 |
| EPS Basic Continuous Ops | 1.36 | 1.39 | 1.41 | 1.62 | 1.67 |
| EPS Diluted Total Ops | 1.36 | 1.38 | 1.40 | 1.61 | 1.66 |
| EPS Diluted Continuous Ops | 1.36 | 1.39 | 1.41 | 1.62 | 1.67 |
| EPS Diluted Before Non-Recurring Items | 2.26 | 2.27 | 1.84 | 2.12 | 2.06 |
| EBITDA(a) | $6,672,998 | $6,254,539 | $5,941,828 | $6,852,615 | $7,027,614 |